AstraZeneca rises 7% after Ranbaxy agrees Nexium deal - Independent

AstraZeneca rises 7% after Ranbaxy agrees Nexium deal Independent, UK - 15 hours ago Under the terms of the deal, Ranbaxy will be able to produce the drug from May 2014, which is when the first patents held by AstraZeneca expire. ... AstraZeneca settles lawsuit with Ranbaxy Guardian AstraZeneca shares soar as patent case settled Times Online AstraZeneca shares soar after Nexium settlement MarketWatch Business Standard - The Associated Press all 210 news articles